Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;2(2):111-7.

Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study

Affiliations

Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study

G Landoni et al. HSR Proc Intensive Care Cardiovasc Anesth. 2010.

Abstract

Introduction: Acute kidney injury requiring renal replacement therapy is a serious complication following cardiac surgery associated with poor clinical outcomes. Until now no drug showed nephroprotective effects. Fenoldopam is a dopamine-1 receptor agonist which seems to be effective in improving postoperative renal function. The aim of this paper is to describe the design of the FENO-HSR study, planned to assess the effect of a continuous infusion of fenoldopam in reducing the need for renal replacement therapy in patients with acute kidney injury after cardiac surgery.

Methods: We're performing a double blind, placebo-controlled multicentre randomized trial in over 20 Italian hospitals. Patients who develop acute renal failure defined as R of RIFLE score following cardiac surgery are randomized to receive a 96-hours continuous infusion of either fenoldopam (0.025-0.3 µg/kg/min) or placebo.

Results: The primary endpoint will be the rate of renal replacement therapy. Secondary endpoints will be: mortality, time on mechanical ventilation, length of intensive care unit and hospital stay, peak serum creatinine and the rate of acute renal failure (following the RIFLE score).

Conclusions: This trial is planned to assess if fenoldopam could improve relevant outcomes in patients undergoing cardiac surgery who develop acute renal dysfunction. Results of this double-blind randomized trial could provide important insights to improve the management strategy of patients at high risk for postoperative acute kidney injury.

Keywords: acute renal failure; anesthesia; cardiac surgery; cardiac surgical procedures; fenoldopam; renal replacement therapy.

PubMed Disclaimer

Figures

Table 1
Table 1
RIFLE score for acute renal failure.
Table 2
Table 2
A clinical score to predict acute renal failure after cardiac surgery according to Tankar et al. (15)
Table 3
Table 3
The Continuous Improvement in Cardiac Surgery Study score (CICSS) by Chertow et al. (16).
Table 4
Table 4
The Simplified model to predict postoperative dialysis by Metha el al. (18).
Table 5
Table 5
A simplified predictive index for renal replacement therapy after cardiac surgery suggested by Wijeysundera et al. (18).

References

    1. Landoni G, Roberti A, Boroli F. et al. Mitral valve surgery and acute renal failure. Eur J Anaesthesiol. 2007;24:100–101. - PubMed
    1. Landoni G, Bove T, Crivellari M. et al. Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol. 2007;73:559–565. - PubMed
    1. Bove T, Calabrò MG, Landoni G. et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:442–445. - PubMed
    1. Landoni G, Zangrillo A, Franco A. et al. Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol. 2006;23:17–22. - PubMed
    1. Schetz M, Bove T, Morelli A. et al. Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs. 2008;31:179–189. - PubMed

LinkOut - more resources